Aquestive therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Aquestive therapeutics Contact Number

Home Aquestive Therapeutics

2 hours ago Aquestive.com Show details

(908) 941-1900By providing my contact information, I agree that Aquestive Therapeutics (“Aquestive”) can use such information for its marketing database and that Aquestive and its agents may contact me by mail or email to provide information about Aquestive or its products or services.

1. 30 Technology Dr, Warren, NJ 07059 · (908) 941-1900DIRECTIONSWEBSITE

Category: Home PhoneShow more

Development & Licensee Services to Support Aquestive

1 hours ago Aquestive.com Show details

Phone number * Tell us how we can assist you. By providing my contact information, I agree that Aquestive Therapeutics (“Aquestive”) can use such information for its marketing database and that Aquestive and its agents may contact me by mail or email to provide information about Aquestive or its products or services. I understand that

Category: Support NumberShow more

Aquestive Therapeutics Crunchbase

9 hours ago Crunchbase.com Show details

908-941-1900Legal Name Aquestive Therapeutics, Inc. Stock Symbol NASDAQ:AQST. Company Type For Profit. Contact Email [email protected]aquestive.com. Phone Number 908-941-1900. Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives.

Founded: 15 Jan, 2004

Category: Contact NumberShow more

Strategic Partnerships Built That Maximize Aquestive

7 hours ago Aquestive.com Show details

Phone number * Tell us how we can assist you. By providing my contact information, I agree that Aquestive Therapeutics (“Aquestive”) can use such information for its marketing database and that Aquestive and its agents may contact me by mail or email to provide information about Aquestive or its products or services. I understand that

Category: Contact NumberShow more

Peter Boyd Aquestive Home Aquestive Therapeutics

7 hours ago Aquestive.com Show details

Phone number * Tell us how we can assist you. By providing my contact information, I agree that Aquestive Therapeutics (“Aquestive”) can use such information for its marketing database and that Aquestive and its agents may contact me by mail or email to provide information about Aquestive or its products or services. I understand that

Category: Home PhoneShow more

Aquestive Therapeutics Marketing Department Aquestive

3 hours ago Rocketreach.co Show details

Find contact info for Aquestive Therapeutics employees Find Info Top Aquestive Therapeutics Employees Gary Slatko. Senior Vice President, Chief Medical Officer Both in the scope of the searches, and in the number of accurate emails found, I find it surpasses others. I also like the layout, which is easy on the eye, more attractive and

Category: Contact NumberShow more

Commitment to Epilepsy Aquestive

4 hours ago Aquestive.com Show details

Phone number * Tell us how we can assist you. By providing my contact information, I agree that Aquestive Therapeutics (“Aquestive”) can use such information for its marketing database and that Aquestive and its agents may contact me by mail or email to provide information about Aquestive or its products or services. I understand that

Category: Contact NumberShow more

Aquestive Therapeutics, Inc. Company Dun & Bradstreet

Just Now Dnb.com Show details

Aquestive Therapeutics, Inc. is located in Warren, NJ, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Aquestive Therapeutics, Inc. has 187 total employees across all of its locations and generates $45.85 million in sales (USD). There are 4 companies in the Aquestive Therapeutics, Inc. corporate family.

Category: Contact NumberShow more

About Us Aquestive

1 hours ago Aquestive.com Show details

By providing my contact information, I agree that Aquestive Therapeutics (“Aquestive”) can use such information for its marketing database and that Aquestive and its agents may contact me by mail or email to provide information about Aquestive or its products or services.

Category: Contact NumberShow more

Keith Kendall Email Address Phone Number Aquestive

7 hours ago Dnb.com Show details

View the business profile and contact info for Keith Kendall, Chief Executive Officer, President And Director at Aquestive Therapeutics, Inc. in New Jersey, US

Category: Phone NumberShow more

Aquestive Therapeutics Company Profile Office Craft

9 hours ago Craft.co Show details

Aquestive Therapeutics has 277 employees at their 1 location and $45.85 M in annual revenue in FY 2020. See insights on Aquestive Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Aquestive Therapeutics, Inc. (Form: S1, Received: 06/27

6 hours ago Content.edgar-online.com Show details

361-18-0301(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices) John T. Maxwell Chief Financial Officer Aquestive Therapeutics, Inc. 30 Technology Drive Warren, NJ 07059 (908) 941-1900

Category: Contact NumberShow more

NEURELIS, INC. v. AQUESTIVE THERAPEUTICS, INC. [RULE 36

9 hours ago Cafc.uscourts.gov Show details

Argument. Scheduled Cases; Daily Schedule; Accessibility Accommodations; Argument Resources; Calendar of Sessions; Courtroom Decorum Policy; Guide for Oral Argument

Category: Contact NumberShow more

Theresa Wood Aquestive Aquestive Therapeutics

9 hours ago Aquestive.com Show details

Theresa Wood has led the Human Resources function since October 2006. Prior to joining Aquestive, Ms. Wood was the Director, Human Resources for Hewlett Packard Financial Services’ Americas division from 1999 to 2006. From 1995 to 1998, Ms. Wood provided consulting services to several companies in the Financial Services, Healthcare and

Category: Contact NumberShow more

Corporate Governance Aquestive Therapeutics

2 hours ago Investors.aquestive.com Show details

From 1985 to 1998, Mr. Kendall held a number of positions with AT&T Capital Corporation, including President of AT&T Credit Corporation and NCR Credit Corporation. Mr. Kendall served on the board of directors of Midatech Pharma Plc (Nasdaq: MTP) from January 2010 to December 2014. Mr.

Category: Contact NumberShow more

IntelGenx and Aquestive Therapeutics Partner with Leading

2 hours ago Eminetracanada.com Show details

(514) 331-7440About Aquestive Therapeutics. Contact Information: Stephen Kilmer Investor Relations (514) 331-7440 ext 232 [email protected] Or. Quebec will coordinate the deployment of the COVID-19 vaccine as the number of Pfizer vaccines available in …

Category: Contact NumberShow more

Aquestive Therapeutics Number of Employees Macrotrends

9 hours ago Macrotrends.net Show details

Aquestive Therapeutics number of employees from 2018 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical

Category: Contact NumberShow more

Aquestive Therapeutics Negotiates Six Month Extension to

8 hours ago Investors.aquestive.com Show details

Provides access to $30 million in capital contingent on FDA approval and U.S. market access for Libervant; WARREN, N.J., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that it …

Category: Contact NumberShow more

Events and Presentations Aquestive Therapeutics

7 hours ago Investors.aquestive.com Show details

The Investor Relations website contains information about Aquestive Therapeutics's business for stockholders, potential investors, and financial analysts.

Category: Contact NumberShow more

Aquestive Therapeutics Reaches Agreement to Extend

6 hours ago Investors.aquestive.com Show details

WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that it has reached an agreement with its lenders providing for a bridge waiver of the first principal payment due …

Category: Contact NumberShow more

Aquestive Therapeutics Receives FDA Fast Track Designation

Just Now Investors.aquestive.com Show details

Finalizing preparations for pharmacokinetic (PK) clinical trials of AQST-108 First planned PK clinical trial expected to begin during the third quarter of 2020 WARREN, N.J. , Aug. 10, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on

Category: Contact NumberShow more

Aquestive Therapeutics, Inc. (AQST) Stock Analysis

6 hours ago Stockanalysis.com Show details

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual

Category: Contact NumberShow more

Aquestive Therapeutics to Participate in Three Investor

8 hours ago Investors.aquestive.com Show details

WARREN, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that the management team will participate in three upcoming investor conferences in September as follows:

Category: Contact NumberShow more

IntelGenx and Aquestive Therapeutics Partner with Leading

2 hours ago Globenewswire.com Show details

(514) 331-7440Contact Information: Stephen Kilmer Investor Relations (514) 331-7440 ext 232 [email protected] Or. Andre Godin, CPA, CA President and …

Category: Contact NumberShow more

Aquestive Stock Price AQST 3.87 0.03 (0.7813000000000001%)

9 hours ago Macroaxis.com Show details

Aquestive Therapeutics is selling for under 3.87 as of the 16th of October 2021; that is 0.78% increase since the beginning of the trading day. The stock's last reported lowest price was 3.82. Get the latest Aquestive Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Aquestive Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

How to buy Aquestive Therapeutics stock 11 Oct price $3.77

Just Now Finder.com Show details

Since the stock market crash in March caused by coronavirus, Aquestive Therapeutics's stock price has had significant negative movement. Its last market close was $4.15, which is 1.66% down on its pre-crash value of $4.22 and 194.33% up on the lowest point reached during the March crash when the stocks fell as low as $1.41.

Category: Contact NumberShow more

Aquestive Therapeutics, Inc. TheStreet

6 hours ago Thestreet.com Show details

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems.

Category: Contact NumberShow more

A Multicenter, Open Label Crossover Study to Assess the

7 hours ago Clinicaltrials.gov Show details

Aquestive Therapeutics 30 Technology Drive Warren, NJ 07059 USA Phase 2 IND Number: 129068 Confidentiality Statement The information in this document is confidential and is not to be disclosed without the written consent of Aquestive Therapeutics except to the extent that disclosure would be

Category: Contact NumberShow more

Aquestive Therapeutics, Inc. DEF 14A Apr. 29, 2020 4:13 PM

9 hours ago Seekingalpha.com Show details

30 Technology Drive. Warren, NJ 07059. Dear Stockholders: On behalf of the Board of Directors of Aquestive Therapeutics, Inc., you are cordially invited to attend the 2020 Annual Meeting of

Category: Contact NumberShow more

Aquestive Therapeutics to Hold VirtualOnly Annual Meeting

2 hours ago Investors.aquestive.com Show details

Notice of Change of Location of Annual Meeting of Stockholders to be held on June 16, 2020 to Virtual-Only Meeting. WARREN, N.J., June 04, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic …

Category: Contact NumberShow more

IntelGenx and Aquestive Therapeutics Partner with Leading

9 hours ago Stocktitan.net Show details

(514) 331-7440About Aquestive Therapeutics. Because these forward-looking statements are subject to a number of risks and uncertainties, IntelGenx's actual results could differ materially from those expressed or implied by these forward-looking statements. Contact Information: Stephen Kilmer Investor Relations (514) 331-7440 ext 232 [email protected]

Category: Contact NumberShow more

IntelGenx and Aquestive Therapeutics Partner with Leading

4 hours ago Finance.yahoo.com Show details

Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients.

1. Author: Intelgenx Corp.

Category: Contact NumberShow more

What is Aquestive Therapeutics Valuation Today Macroaxis

3 hours ago Macroaxis.com Show details

Aquestive Therapeutics shows a prevailing Real Value of $6.84 per share. The current price of the firm is $3.87. At this time, the firm appears to be undervalued.Our model approximates the value of Aquestive Therapeutics from analyzing the firm fundamentals such as Profit Margin of (152.73) %, current valuation of 154.44 M, and Return On Equity of 0.0003 % as well as examining its technical

Category: Contact NumberShow more

Aquestive Therapeutics to Participate in 2021 RBC Yahoo

9 hours ago Finance.yahoo.com Show details

WARREN, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address

Category: Contact NumberShow more

Aquestive Therapeutics: Remaining Bullish SeekingAlpha

2 hours ago Seekingalpha.com Show details

Aquestive Therapeutics is a world leader in oral film drug delivery with its PharmFilm technology. Its lead product candidate, Libervant, is moving closer to NDA resubmission by the Q2 end.

Category: Contact NumberShow more

Aquestive Therapeutics, Inc Glancy Prongay & Murray LLP

9 hours ago Glancylaw.com Show details

Aquestive Therapeutics, Inc. Stock Symbol. AQST. Class Period. December 02, 2019 to September 25, 2020. Lead Plaintiff Motion Deadline. April 30, 2021. Aquestive is a specialty pharmaceutical company. Its most advanced proprietary product candidate is Libervant, a buccal soluble film formulation of diazepam for the treatment of recurrent

Category: Contact NumberShow more

Aquestive Therapeutics Earnings Preview Yahoo Finance

5 hours ago Finance.yahoo.com Show details

EPS equals to net income divided by the number of shares outstanding. Earnings And Revenue Analysts are predicting Aquestive Therapeutics will report a loss of $0.26 per share on revenue of $6.24

Category: Contact NumberShow more

Mitsubishi Tanabe Pharma America and Aquestive

5 hours ago Apnews.com Show details

JERSEY CITY, N.J. and WARREN, N.J., Jan. 21, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) and Aquestive Therapeutics, Inc. (NASDAQ: AQST) today announced a licensing and supply deal for the U.S. rights to commercialize EXSERVAN™ (riluzole), an oral film formulation of riluzole for the treatment of amyotrophic lateral sclerosis (ALS).

Category: Contact NumberShow more

Is Aquestive Therapeutics, Inc. (AQST) A Good Yahoo

2 hours ago Finance.yahoo.com Show details

Aquestive Therapeutics, Inc. (NASDAQ: AQST) was in 5 hedge funds' portfolios at the end of March. The all time high for this statistic is 15. There were 9 …

Category: Contact NumberShow more

AQST Shareholder Alert: Bronstein, Gewirtz Yahoo

6 hours ago Finance.yahoo.com Show details

AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

Category: Contact NumberShow more

Aquestive Therapeutics Reports First Quarter 2021 Yahoo

Just Now Finance.yahoo.com Show details

Aquestive saw net revenue growth in the first quarter 2021, compared to the prior year period, of 56% for Sympazan, the first of its proprietary products to …

Category: Contact NumberShow more

What Type Of Shareholders Own The Most Number of Yahoo

9 hours ago Finance.yahoo.com Show details

The general public holds a 36% stake in Aquestive Therapeutics. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run. Next Steps:

Category: Contact NumberShow more

Form 4 Aquestive Therapeutics, For: Aug 26 Filed by

Just Now Streetinsider.com Show details

Form 4 Aquestive Therapeutics, For: Aug 26 Filed by: Kendall Keith J Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Contact Us Disclaimer

Category: Contact NumberShow more

Aquestive Stock Stock News Macroaxis

8 hours ago Macroaxis.com Show details

Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aquestive Therapeutics' price.

Category: Contact NumberShow more

Aquestive Reviews Glassdoor

2 hours ago Glassdoor.com Show details

Cons. Aquestive is experiencing growing pains. They're unsure of what the backbone of their company is supposed to look like, which is why there has been a high turnover rate since the launch of their first sales force in 2018. The expectations and pressures are high.

Category: Contact NumberShow more

Aquestive Therapeutics Completes $70 Million Debt Refinancing

6 hours ago Prnewswire.com Show details

Aquestive Therapeutics Completes $70 Million Debt Refinancing. WARREN, N.J., July 15, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive"), a specialty pharmaceutical

Category: Contact NumberShow more

How to buy Aquestive Therapeutics stock (NASDAQ: AQST

5 hours ago Finder.com Show details

Over the last 12 months, Aquestive Therapeutics's shares have ranged in value from as little as $3.1 up to $9.32. A popular way to gauge a stock's volatility is its "beta". Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aquestive Therapeutics's is 3.6134.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is aquestive Therapeutics?

Aquestive Therapeutics is a commercial-stage pharmaceutical company inspired to develop and commercialize unique therapies to fulfill unmet medical needs. In addition to its commercial products, the company has a late-stage CNS proprietary pipeline that could create a beachhead for the company in the CNS population.

How does aquestive Therapeutics help patients with epilepsy?

Our innovations in oral drug delivery aim to improve the treatment experience for patients with epilepsy and their caregivers who struggle with difficult or invasive modes of administration, complex treatment regimens, and inconsistent dosing and drug delivery. 2 Our efforts to help patients and families extend beyond the clinic.

How is pharmfilm used in aquestive Therapeutics?

PharmFilm® is a versatile, high-performance drug delivery technology that can be uniquely tailored to achieve a desired product profile with optimized absorption, bioavailability, and onset of action. See how Aquestive is changing drug delivery to deliver meaningful clinical and therapeutic advances.

How many doses of oral film has aquestive sold?

12 years. 2+ billion doses and counting. 2B+ doses consumed. 200+ patents provide strong intellectual property. Aquestive is the worldwide leader in delivering trusted, quality medications on oral film.

Popular Brands

Amazon
Abbvie
Aia
Asml
Att
Amgen
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes